Shu Chien joined UCSD in 1988 and became the founding chair of the Department of Bioengineering in 1994. In 2008, Chien became the founding Director of UC San Diego’s new Institute of Engineering in Medicine. As principal investigator on the Whitaker Foundation Development Award (1993) and Leadership Award (1998), Chien played a major role in establishing UCSD’ bioengineering program as one of the top in the country. As founding Director of the Whitaker Institute of Biomedical Engineering at UCSD, he helps foster collaborations among the faculty of UCSD and with research institutes and biomedical companies in San Diego. As founding Director of the UC Systemwide Bioengineering Institute in California, he has facilitated collaborations in research and education among the ten UC campuses. In September 2006, Chien was named the inaugural holder of the Y.C. Fung Endowed Chair in Bioengineering at the Jacobs School. He is a member of the National Academy of Engineering, Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences. He received the National Medal of Science, the highest honor in science and engineering in the United States, in 2011. He received his M.D. from the National Taiwan University and his Ph.D. in Physiology from Columbia University, where he was a professor from 1969 to 1988.
Molecular, cellular, and integrative bioengineering, with focus areas on mechanotransduction and mechanobiology of endothelial cells and role of extracellular environment in regulation of stem cell fate.
University professor Maria Tomoaia-Cotisel completed PhD at Babes-Bolyai University (BBU, 1979) of Cluj-Napoca, Romania, and postdoctoral studies from London University, King’s College (1981, 1986, 1989), UK. She was the visiting scientist at Philipps University of Marburg, (1989/1990), Germany, State University of New York at Buffalo (1990/1991), US, National Institutes of Health, (1991-1993), and Molecular/Structural Biotech., Inc., (1994-1997), Bethesda, MD, USA. She is the founder and director of Research Center in Physical Chemistry (RC, 2007- ) at BBU. She has been the manager of various research programs with extensive collaboration with academia and industry, developing several new laboratories in RC with state-of-the art equipment for processing and characterization of innovative nanomaterials, thin coating layers and scaffolds, self-assembled layers at various interfaces, including Langmuir-Blodgett layers, as well bio-complexes for drug delivery systems. She also contributed to the development of a large infrastructure belonging to STAR Institute in BBU. She has wide experience in research, innovation and development of advanced nanomaterials and smart engineering materials, such as ceramics as well nanoparticles of gold and silver, using eco-friendly and cost-effective material processing technologies, leading to high performance of multi-functional materials and composites, especially for biomedical applications. She got awards, e.g., Gheorghe Spacu Award (1983, from the Romanian Academy), Alexander von Humboldt Award (1986, Germany), Japan Society for Promotion of Science and Technology Award (1988, Japan) and Fogarty Award (1991, USA) for science and technology. She is leading a multidisciplinary research team using cutting edge technologies ranging from physical chemists, biologists, material scientists, chemical and surface engineers, working on innovative nanostructured biomaterials, coating layers on various substrates, nanostructured scaffolds for cell culture, coated implants to be used in vivo, Langmuir-Blodgett self-assembled layers of fatty acids, lipids, carbohydrates and proteins as models of biological membranes and drug delivery systems, as well as nanocomposites for environmental science, health care and nanomedicine applications. She is a corresponding member of the Academy of Romanian Scientists. She published over 250 original scientific research papers, starting from biomolecules, through self-assembled layers at diverse interfaces, to various nanomaterials for hard tissue engineering; four US patents on pioneering intelligent bio-conjugates with high capacity for crossing the blood brain barrier to treat various disorders of the central nervous system and one Romanian patent for bone substitutes and tissue engineering; and 10 books in physical chemistry, including thermodynamics, chemical structure, biophysics, bionanomaterials, colloids and interfaces. She has given over 160 invited lectures / keynote presentations and conducted many conference sessions as Chairperson.
Nanomaterials, advanced nanotechnology for biomedical applications, nanostructured advanced biomaterials, multi-substituted hydroxyapatite based bioceramics for osteoporotic bone remodeling and regeneration, nanomaterials for tissue engineering, nanomicrobials, biocomposites, biomimetic self-assembled scaffolds, porous bioresorbable scaffolds, regenerative medicine, cancer cellular therapy, nanoparticles of gold and silver for cancer therapy, nanoscale materials for drug delivery, as well as biomolecular immobilization and surface modification strategies
Yuncang Li obtained his Ph.D. in Materials Science Engineering from Deakin University in 2004 and then took up a research position in Biomaterials Engineering at Deakin University until the end of 2014. He joined RMIT University in 2015. He was awarded an Australian Research Council (ARC) Future Fellowship and won a number of nationally competitive grants including ARC and Australian National Health and Medical Research Council projects. His research focuses on developing metallic biomaterials for medical applications. He has expertise in microstructure-mechanical property relationships, corrosion, and biocompatibility, surface modification, nanostructured metals and alloys, and metal foams. His research has led to 184 peer-reviewed original publications, with an H index of 31 and over 3180 citations (Google Scholar).
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.
Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Director, Center for Personalized Medicine, Sechenov University and Chair,Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born on 11 Jan 1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Institute in Moscow; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA; Chair, Department for Clinical Immunology, Moscow Clinical Research Institute; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels.
Cancer Immunology, Preventive and Personalized Medicine,Immunology, Medicine, Pathology, Clinical Immunology,Biomedical Sciences
Dr. Omid Akbarzadeh is working with Nanotechnology and Catalysis Research Centre since 2016. His main research area is heterogeneous catalysis and catalytic reaction engineering. He has spent 10 years in academic-industrial projects as a research officer and post-doctoral. Dr. Omid has worked 5 years in the oil and gas industry as a chemical engineer. He developed advance smart catalysts especially for oil and gas industries. Dr. Omid has contributed to two PETRONAS Research Sdn Bhd industrial catalyst projects and worked on international Airbus R&D project in NANOCAT. Currently, he is the PI of graphene catalyst project in Hokkaido University in Japan, project member of FRGS grant in UTP and assigned to the NANOCAT center project. Dr. Omid was the Chairman, keynote speaker and organizing committee of many international conferences. He is currently supervisor of a few postgraduate students. He has published many ISI papers; book chapters and has two approved and granted patents. Also, he has hands-on experience and passed several pieces of training on handling different types of equipment which are being widely used for material synthesis, characterization and performance evaluation. He is in close collaboration with other departments, government agencies and universities around the world. He is visiting researcher of Jiangsu University China and Hokkaido University Japan. He is member of the society of petroleum engineers (SPE) and Senior Member of Hong Kong Chemical, Biological & Environmental Engineering Society. Omid awarded full fellowship from UTP during Ph.D and were involved for lab demonstrator and teaching in the different courses of chemical engineering. He awarded Silver Medal in 27th International Invention & Innovation Exhibition (ITEX 2016), Kuala Lumpur Convention Center in Malaysia and Silver Medal of Post Graduate Research Project in 35th Science & Engineering Design Exhibition (SEDEX 35).
Nanotechnology & Catalysis